BioNTech to Host Innovation Series R&D Day on November 11, 2025

Core Insights - BioNTech will host an Innovation Series R&D Day on November 11, 2025, to discuss its strategy and clinical progress [1] - The event will be accessible online, with a replay available for one year [2] Company Overview - BioNTech is a global next-generation immunotherapy company focused on developing novel therapies for cancer and serious diseases [3] - The company utilizes a variety of computational discovery and therapeutic modalities for rapid biopharmaceutical development [3] - BioNTech's oncology portfolio includes mRNA cancer immunotherapies, immunomodulators, targeted therapies like antibody-drug conjugates (ADCs), and CAR T cell therapies [3] - The company is also developing multiple mRNA vaccine candidates for infectious diseases alongside its oncology pipeline [3] - BioNTech collaborates with several global pharmaceutical companies, including Bristol Myers Squibb, Pfizer, and Roche [3]